- Report
- June 2022
- 99 Pages
Global
From €3500EUR$4,117USD£3,115GBP
- Report
- August 2023
- 90 Pages
Global
From €3500EUR$4,117USD£3,115GBP
- Report
- May 2023
- 78 Pages
Global
From €3500EUR$4,117USD£3,115GBP
- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£744GBP
- Report
- September 2021
- 198 Pages
Global
From €3380EUR$3,712USD£2,907GBP
Central Nervous System (CNS) Stimulants are a class of drugs used to treat a variety of conditions, including attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity. These drugs work by increasing the activity of certain neurotransmitters in the brain, such as dopamine and norepinephrine, which can improve focus and alertness. Common side effects of CNS stimulants include insomnia, anxiety, and increased heart rate.
CNS stimulants are typically prescribed by a doctor and are available in both short- and long-acting forms. Short-acting forms are taken as needed, while long-acting forms are taken once daily. These drugs are generally considered safe when taken as prescribed, but they can be abused and can lead to addiction.
Some of the major companies in the CNS stimulants market include Shire, Novartis, Johnson & Johnson, Pfizer, and GlaxoSmithKline. These companies produce a variety of CNS stimulants, including methylphenidate, amphetamine, and lisdexamfetamine. Show Less Read more